Initiated by Antoni van Leeuwenhoek - Netherlands Cancer Institute 

Prof. Marie-Jeanne Vrancken Peeters, MD, PhD, surgical oncology

Vincent Dezentjé, MD, PhD, medical oncology

Astrid Scholten, MD, PhD, radiation oncology

Nina Bijker, PhD, radiation oncology

Tess Snellen, PhD candidate

Charlotte Vervenne, PhD candidate

Welcome,

The Breast Cancer Recurrence Consortium (BCRC) is a nationwide and multidiscplinary consortium including oncological surgeons, medical oncologists, radiation oncologists and pathologists. 

Isolated locoregional breast cancer recurrence is defined as relapse of disease in ipsilateral breast, chest wall, axilla, infraclavicular, supraclavicular or parasternal lymph nodes.[1] Estimated incidence is 0,5-1,5% per year, with a total incidence of 5-10% in 10-year follow-up.[2] Per year 2.3 million people are diagnosed with breast cancer[3], therefore the number of patients diagnosed with locoregional breast cancer recurrence is substantial. However, there are no clear guidelines. 

Our aim is to gain insight in questions regarding locoregional breast cancer recurrence to achieve optimilization of multimodality treatment of the individual patient and implementation in guidelines.

We want to achieve this by:

• National cooperation
• Multidisciplinary approach
• Data collection and merging

• Initiation of (multicenter) clinical studies

Do you want to participate?

Please contact one of us or send

an email to bcrc@nki.nl

References

1. UICC, 2002

2. Houvenaeghel 2018, Wapnir 2006, Anderson 2009

3. Sung 2020